Transaction in Own Shares

NatWest Group plc
13 March 2024
 










NatWest Group plc

 


13 March 2024




Transaction in Own Shares

 


NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS') across two transactions, Transaction 1 and Transaction 2 (together the 'Transactions').













The purchases form part of the Company's existing share buyback programmes, with Transaction 1 purchases effected pursuant to the instructions issued by the Company to UBS on 28 July 2023, as announced on 31 July 2023 and Transaction 2 purchases effected pursuant to the instructions issued by the Company to UBS on 16 February 2024, as announced on 19 February 2024.













Aggregated information relating to the Transactions is set out in the tables below.













Transaction 1:

 

















Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume  weighted average price paid per share (GBp)

Venue




13 March 2024

0

0.00

0.00

0.0000

LSE




13 March 2024

0

0.00

0.00

0.0000

CHIX




13 March 2024

0

0.00

0.00

0.0000

BATE













Transaction 2:

 

















Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume  weighted average price paid per share (GBp)

Venue




13 March 2024

4,773

254.40

253.30

253.9737

LSE




13 March 2024

1,599

253.60

253.60

253.6000

CHIX




13 March 2024

3,121

254.20

253.70

253.9695

BATE













* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share













The Company intends to cancel all of the Ordinary Shares repurchased under the Transactions. Following the settlement of the transactions, the Company will hold 151,511,323 Ordinary Shares in treasury and have 8,773,240,500 Ordinary Shares in issue (excluding treasury shares).













Further information:












Investor Relations









+ 44 (0)207 672 1758


















Media Relations









+44 (0)131 523 4205


















Legal Entity Identifier: 2138005O9XJIJN4JPN90












Details of the Transactions

 







In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programmes relating to the Transactions is detailed below:













Transaction 2:

 








Transaction Date

Time

Time Zone

Volume (shares)

Price (GBp)

Trading Venue

MatchID



13 March 2024

08:00:12

BST

395

253.80

BATE

1366074



13 March 2024

08:00:12

BST

402

254.00

BATE

1366072



13 March 2024

08:00:12

BST

235

254.00

BATE

1366070



13 March 2024

08:00:12

BST

685

254.10

BATE

1365996



13 March 2024

08:00:12

BST

622

254.20

BATE

1365994



13 March 2024

08:00:12

BST

51

254.20

BATE

1365992



13 March 2024

08:00:14

BST

731

253.70

BATE

1366399



13 March 2024

08:01:00

BST

106

253.60

CHIX

1370015



13 March 2024

08:01:00

BST

1493

253.60

CHIX

1370013



13 March 2024

08:00:10

BST

1009

254.40

LSE

1365638



13 March 2024

08:00:12

BST

1637

254.30

LSE

1365972



13 March 2024

08:00:14

BST

1172

253.70

LSE

1366397



13 March 2024

08:01:24

BST

955

253.30

LSE

1370366





























 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings